ID
31613
Beschrijving
Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients; ODM derived from: https://clinicaltrials.gov/show/NCT02114658 Sponsor: Bayer Information provided by (Responsible Party): Bayer
Link
https://clinicaltrials.gov/show/NCT02114658
Trefwoorden
Versies (1)
- 12-09-18 12-09-18 -
Houder van rechten
Bayer
Geüploaded op
12 september 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Thyroid Carcinoma NCT02114658
Eligibility Thyroid Carcinoma NCT02114658
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Histologic subtypes of thyroid cancer other than anaplastic or medullary carcinoma
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0007115
- UMLS CUI [1,2]
- C0205394
- UMLS CUI [1,3]
- C0449560
Beschrijving
Prior anti-cancer targeted therapy including tyrosine kinase inhibitors, monoclonal antibodies that target vegf or vegf receptors
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0920425
- UMLS CUI [1,2]
- C0879484
- UMLS CUI [2,1]
- C0920425
- UMLS CUI [2,2]
- C2267081
- UMLS CUI [3,1]
- C0920425
- UMLS CUI [3,2]
- C2917234
- UMLS CUI [4,1]
- C0920425
- UMLS CUI [4,2]
- C2985566
Beschrijving
Prior chemotherapy for thyroid cancer
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514457
- UMLS CUI [1,2]
- C0007115
Beschrijving
Major surgery, open biopsy or significant traumatic injury within 30 days prior to enrollment in the study
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0332185
- UMLS CUI [1,2]
- C0679637
- UMLS CUI [2,1]
- C0332185
- UMLS CUI [2,2]
- C0184922
- UMLS CUI [3,1]
- C0332185
- UMLS CUI [3,2]
- C3263723
Beschrijving
Subjects with tracheal, bronchial or esophageal infiltration with significant risk of bleeding
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0332448
- UMLS CUI [1,2]
- C0040578
- UMLS CUI [1,3]
- C3251812
- UMLS CUI [2,1]
- C0332448
- UMLS CUI [2,2]
- C0006255
- UMLS CUI [2,3]
- C3251812
- UMLS CUI [3,1]
- C0332448
- UMLS CUI [3,2]
- C0014876
- UMLS CUI [3,3]
- C3251812
Similar models
Eligibility Thyroid Carcinoma NCT02114658
- StudyEvent: Eligibility
C0238461 (UMLS CUI [2])
C0238462 (UMLS CUI [3,1])
C0677984 (UMLS CUI [3,2])
C0238462 (UMLS CUI [4,1])
C0036525 (UMLS CUI [4,2])
C0543467 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,3])
C1512714 (UMLS CUI [2,1])
C1522449 (UMLS CUI [2,2])
C1276305 (UMLS CUI [2,3])
C0238461 (UMLS CUI [1,2])
C1265900 (UMLS CUI [2,1])
C0238461 (UMLS CUI [2,2])
C0449575 (UMLS CUI [3,1])
C0238462 (UMLS CUI [3,2])
C1265900 (UMLS CUI [4,1])
C0238462 (UMLS CUI [4,2])
C1709926 (UMLS CUI [1,2])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0205394 (UMLS CUI [1,2])
C0449560 (UMLS CUI [1,3])
C0879484 (UMLS CUI [1,2])
C0920425 (UMLS CUI [2,1])
C2267081 (UMLS CUI [2,2])
C0920425 (UMLS CUI [3,1])
C2917234 (UMLS CUI [3,2])
C0920425 (UMLS CUI [4,1])
C2985566 (UMLS CUI [4,2])
C0007115 (UMLS CUI [1,2])
C0679637 (UMLS CUI [1,2])
C0332185 (UMLS CUI [2,1])
C0184922 (UMLS CUI [2,2])
C0332185 (UMLS CUI [3,1])
C3263723 (UMLS CUI [3,2])
C0040578 (UMLS CUI [1,2])
C3251812 (UMLS CUI [1,3])
C0332448 (UMLS CUI [2,1])
C0006255 (UMLS CUI [2,2])
C3251812 (UMLS CUI [2,3])
C0332448 (UMLS CUI [3,1])
C0014876 (UMLS CUI [3,2])
C3251812 (UMLS CUI [3,3])